Ophthalmology · Lilburn, GA
NPI
1992702450
Since 2005
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
3975 Lawrenceville Hwy NW
Lilburn, GA, 30047
Phone (770) 923-5000
Groups this clinician bills Medicare through
Medicare paid, 2024
$165K
1,977 services
Medicare patients, 2024
701
Average age 76
Drug cost, 2024
$370K
1,681 prescriptions
Company payments, 2025
$1,239
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jeffrey A Carlisle was code 92014 (ophthalmological e&m), 526 times for 489 patients. In total Jeffrey A Carlisle billed 1,977 services in 38 codes, and Medicare paid $165K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92014 Ophthalmological E&M | Office | 526 | 489 | $82.55 | $43K |
| 92012 Ophthalmological E&M | Office | 200 | 162 | $63.86 | $13K |
| 92250 Angiography | Office | 172 | 161 | $24.82 | $4,269 |
| 92133 Computerized Ophthalmic Imaging | Office | 148 | 141 | $23.46 | $3,472 |
| 92083 Vision, Hearing, and Speech Services | Office | 129 | 123 | $42.71 | $5,509 |
| 92136 Ultrasound - Nonspecific | Office | 119 | 75 | $28.76 | $3,423 |
| 92004 Ophthalmological E&M | Office | 114 | 114 | $89.72 | $10K |
| 66984 Cataract Surgery | Facility | 93 | 55 | $410.88 | $38K |
| 66821 Cataract Surgery | Office | 76 | 56 | $245.96 | $19K |
| 99213 Office E&M - Established | Office | 37 | 37 | $41.52 | $1,536 |
| 92020 Ophthalmological E&M | Office | 27 | 26 | $20.59 | $556 |
| 92134 Computerized Ophthalmic Imaging | Office | 24 | 24 | $30.25 | $726 |
| 66982 Cataract Surgery | Facility | 17 | 14 | $577.03 | $9,810 |
| 99214 Office E&M - Established | Office | 15 | 15 | $63.75 | $956 |
| 92002 Ophthalmological E&M | Office | 13 | 13 | $61.12 | $795 |
By year: 2022 $205K for 2,228 services; 2023 $173K for 1,973 services; 2024 $165K for 1,977 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jeffrey A Carlisle prescribed most often to Medicare patients was Neomycin-Polymyxin-Dexameth (Neomycin/Polymyxin B/Dexametha), with 309 prescriptions and refills. In total Jeffrey A Carlisle wrote 1,681 Medicare prescriptions that cost $370K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 309 | 325 | 198 | $3,220 |
| Latanoprost Generic | 261 | 569 | 88 | $2,167 |
| Lumigan Bimatoprost | 178 | 309 | 50 | $88K |
| Carteolol Hcl Generic | 175 | 333 | 67 | $5,239 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 74 | 146 | 21 | $798 |
| Travoprost Generic | 71 | 129 | 26 | $9,623 |
| Erythromycin Erythromycin Base | 70 | 73 | 50 | $645 |
| Restasis Cyclosporine | 53 | 86 | 24 | $50K |
| Ketorolac Tromethamine Generic | 47 | 61 | 28 | $1,006 |
| Loteprednol Etabonate Generic | 42 | 52 | 39 | $8,001 |
| Timolol Maleate Generic | 42 | 100 | 14 | $275 |
| Brimonidine Tartrate Generic | 40 | 76 | 13 | $652 |
| Vyzulta Latanoprostene Bunod | 38 | 60 | Under 11 | $18K |
| Diclofenac Sodium Generic | 35 | 40 | 30 | $402 |
| Combigan Brimonidine Tartrate/Timolol | 25 | 46 | Under 11 | $12K |
Brand drugs: 523 claims; generic drugs: 1,158 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeffrey A Carlisle $1,239 ($1,239 in general payments such as food, travel and fees) from 11 companies. The largest payer was Glaukos Corporation with $335.
| Company | Payments | Amount |
|---|---|---|
| Glaukos Corporation GKOS | 3 | $335 |
| Alcon Vision LLC ALC | 3 | $197 |
| Abbvie Inc. ABBV | 5 | $192 |
| Johnson & Johnson Surgical Vision, Inc. JNJ | 3 | $168 |
| Biotissue Holdings Inc. | 1 | $122 |
| Bausch & Lomb Americas Inc. BLCO | 1 | $105 |
| RxSight Inc RXST | 1 | $28.96 |
| Tarsus Pharmaceuticals, Inc. TARS | 1 | $25.29 |
| Dompe US, Inc. | 1 | $23.85 |
| Harrow Eye, LLC | 1 | $23.37 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.